207 related articles for article (PubMed ID: 32482763)
21. Not your average joint: Towards precision medicine in psoriatic arthritis.
Castillo R; Scher JU
Clin Immunol; 2020 Aug; 217():108470. PubMed ID: 32473975
[TBL] [Abstract][Full Text] [Related]
22. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.
Coates LC; Kavanaugh A; Mease PJ; Soriano ER; Laura Acosta-Felquer M; Armstrong AW; Bautista-Molano W; Boehncke WH; Campbell W; Cauli A; Espinoza LR; FitzGerald O; Gladman DD; Gottlieb A; Helliwell PS; Husni ME; Love TJ; Lubrano E; McHugh N; Nash P; Ogdie A; Orbai AM; Parkinson A; O'Sullivan D; Rosen CF; Schwartzman S; Siegel EL; Toloza S; Tuong W; Ritchlin CT
Arthritis Rheumatol; 2016 May; 68(5):1060-71. PubMed ID: 26749174
[TBL] [Abstract][Full Text] [Related]
23. GRAPPA Trainees Symposium 2019: A Report from the GRAPPA 2019 Annual Meeting.
Hughes CD; van Mens LJJ; Boehncke WH; Ritchlin CT
J Rheumatol Suppl; 2020 Jun; 96():4-10. PubMed ID: 32482761
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic immunomodulation and cutaneous malignancy in rheumatoid arthritis, psoriasis, and psoriatic arthritis.
Krathen MS; Gottlieb AB; Mease PJ
J Rheumatol; 2010 Nov; 37(11):2205-15. PubMed ID: 20810498
[TBL] [Abstract][Full Text] [Related]
25. Psoriasis and Psoriatic Arthritis: Flip Sides of the Coin?
Boehncke WH
Acta Derm Venereol; 2016 May; 96(4):436-41. PubMed ID: 26928459
[TBL] [Abstract][Full Text] [Related]
26. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey.
Lebwohl MG; Bachelez H; Barker J; Girolomoni G; Kavanaugh A; Langley RG; Paul CF; Puig L; Reich K; van de Kerkhof PC
J Am Acad Dermatol; 2014 May; 70(5):871-81.e1-30. PubMed ID: 24576585
[TBL] [Abstract][Full Text] [Related]
27. Pediatric psoriasis and psoriatic arthritis.
Lewkowicz D; Gottlieb AB
Dermatol Ther; 2004; 17(5):364-75. PubMed ID: 15379771
[TBL] [Abstract][Full Text] [Related]
28. Assessing disease activity in psoriasis and psoriatic arthritis: impact on management and therapy.
Chandran V; Maharaj AB
Expert Rev Clin Immunol; 2016; 12(5):573-82. PubMed ID: 26807494
[TBL] [Abstract][Full Text] [Related]
29. Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Helliwell PS; Gladman DD; Gottlieb AB
J Rheumatol Suppl; 2018 Jun; 94():1-3. PubMed ID: 29858345
[TBL] [Abstract][Full Text] [Related]
30. Unraveling the complexities of psoriatic arthritis by the use of -Omics and their relevance for clinical care.
Grivas A; Fragoulis G; Garantziotis P; Banos A; Nikiphorou E; Boumpas D
Autoimmun Rev; 2021 Nov; 20(11):102949. PubMed ID: 34509654
[TBL] [Abstract][Full Text] [Related]
31. Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting.
Jadon DR; Chandran V; Stober C; Ogdie A; Armstrong AW; Callis Duffin K; Gladman DD; Helliwell PS; O'Sullivan D; de Wit M; FitzGerald O; Ritchlin CT
J Rheumatol Suppl; 2018 Jun; 94():54-61. PubMed ID: 29858357
[TBL] [Abstract][Full Text] [Related]
32. Unmet needs in psoriatic arthritis.
Ng BCK; Jadon DR
Best Pract Res Clin Rheumatol; 2021 Jun; 35(2):101693. PubMed ID: 34099367
[TBL] [Abstract][Full Text] [Related]
33. Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).
Duvetorp A; Østergaard M; Skov L; Seifert O; Tveit KS; Danielsen K; Iversen L
Arch Dermatol Res; 2019 Jul; 311(5):351-360. PubMed ID: 30868221
[TBL] [Abstract][Full Text] [Related]
34. Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Boehncke WH; Gladman DD
J Rheumatol; 2014 Jun; 41(6):1194-6. PubMed ID: 24882850
[TBL] [Abstract][Full Text] [Related]
35. International Treatment Recommendations Update: A Report from the GRAPPA 2016 Annual Meeting.
Coates LC; Chandran V; Ogdie A; O'Sullivan D; Brooke M; Steinkoenig I; Mease PJ; Ritchlin CT; Kavanaugh A
J Rheumatol; 2017 May; 44(5):684-685. PubMed ID: 28461525
[TBL] [Abstract][Full Text] [Related]
36. Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines.
Kavanaugh AF; Ritchlin CT;
J Rheumatol; 2006 Jul; 33(7):1417-21. PubMed ID: 16724373
[TBL] [Abstract][Full Text] [Related]
37. GRAPPA 2018 Project Report.
Goel N; FitzGerald O; Gladman DD; Helliwell PS; Kavanaugh A; Maksymowych WP; Mease PJ; Ritchlin CT; Coates LC
J Rheumatol Suppl; 2019 Jun; 95():54-57. PubMed ID: 31154406
[TBL] [Abstract][Full Text] [Related]
38. Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only : results of the 2005 Spring US National Psoriasis Foundation Survey.
Ciocon DH; Horn EJ; Kimball AB
Am J Clin Dermatol; 2008; 9(2):111-7. PubMed ID: 18284265
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting.
Boehncke WH; Gladman DD; Chandran V
J Rheumatol; 2011 Mar; 38(3):567-71. PubMed ID: 21362790
[TBL] [Abstract][Full Text] [Related]
40. Verna Wright Lecture: Psoriatic Arthritis: The Need for Early Intervention.
McHugh NJ
J Rheumatol Suppl; 2015 Nov; 93():10-3. PubMed ID: 26523046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
